CORPORATE GOVERNANCE STATEMENT FOR THE YEAR ENDED 30 JUNE 2026 (ASX: BIT) This Corporate Governance Statement is current as at 27 August 2026 and has been approved by the Board of Biotron Limited ( ‘Biotron’ or ‘the Company’) , on that date. A copy can be found on the ...
Corporate Governance Statement
Filed with ASX · · 9 pages · English
Release
Earlier from Biotron
- Full Year Statutory Accounts and Appendix 4E
- Change in substantial holding
- HBV Treatment to Progress Towards Human Trials
- Sedarex First Milestone Met
- $525K R&D Rebate Received
Later from Biotron
- Appendix 4G
- Investor Presentation
- Change of Share Registry
- Resignation of Managing Director and Appendix 3Z
- Appointment of CEO and Executive Director
Follow Biotron into a list and get an email when it puts out news.
Follow Biotron